Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas

Ryan P. Lange, Allen Everett, Pratima Dulloor, Frederick K. Korley, Chetan Bettegowda, Cherie Blair, Stuart A. Grossman, Matthias Holdhoff

Research output: Contribution to journalArticlepeer-review

Abstract

Eight brain-derived proteins were evaluated regarding their potential for further development as a blood-based biomarker for malignant gliomas. Plasma levels for glial fibrillary acidic protein, neurogranin, brain-derived neurotrophic factor, intracellular adhesion molecule 5, metallothionein-3, beta-synuclein, S100 and neuron specific enolase were tested in plasma of 23 patients with high-grade gliomas (WHO grade IV), 11 low-grade gliomas (WHO grade II), and 15 healthy subjects. Compared to the healthy controls, none of the proteins appeared to be specific for glioblastomas. However, the data are suggestive of higher protein levels in gliosarcomas (n = 2), which may deserve further exploration. Copyright

Original languageEnglish (US)
Pages (from-to)423-429
Number of pages7
JournalCancer Investigation
Volume32
Issue number8
DOIs
StatePublished - Sep 14 2014

Keywords

  • Brain Tumors
  • Cancer Biomarkers
  • Circulating Biomarkers
  • Glioma
  • Proteins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas'. Together they form a unique fingerprint.

Cite this